Cargando…

Plasmodium berghei NK65 in Combination with IFN-γ Induces Endothelial Glucocorticoid Resistance via Sustained Activation of p38 and JNK

Malaria-associated acute respiratory distress syndrome (MA-ARDS) is an often lethal complication of malaria. Currently, no adequate therapy for this syndrome exists. Although glucocorticoids (GCs) have been used to improve clinical outcome of ARDS, their therapeutic benefits remain unclear. We previ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zielińska, Karolina A., de Cauwer, Lode, Knoops, Sofie, Van der Molen, Kristof, Sneyers, Alexander, Thommis, Jonathan, De Souza, J. Brian, Opdenakker, Ghislain, De Bosscher, Karolien, Van den Steen, Philippe E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625030/
https://www.ncbi.nlm.nih.gov/pubmed/29033931
http://dx.doi.org/10.3389/fimmu.2017.01199
_version_ 1783268338529468416
author Zielińska, Karolina A.
de Cauwer, Lode
Knoops, Sofie
Van der Molen, Kristof
Sneyers, Alexander
Thommis, Jonathan
De Souza, J. Brian
Opdenakker, Ghislain
De Bosscher, Karolien
Van den Steen, Philippe E.
author_facet Zielińska, Karolina A.
de Cauwer, Lode
Knoops, Sofie
Van der Molen, Kristof
Sneyers, Alexander
Thommis, Jonathan
De Souza, J. Brian
Opdenakker, Ghislain
De Bosscher, Karolien
Van den Steen, Philippe E.
author_sort Zielińska, Karolina A.
collection PubMed
description Malaria-associated acute respiratory distress syndrome (MA-ARDS) is an often lethal complication of malaria. Currently, no adequate therapy for this syndrome exists. Although glucocorticoids (GCs) have been used to improve clinical outcome of ARDS, their therapeutic benefits remain unclear. We previously developed a mouse model of MA-ARDS, in which dexamethasone treatment revealed GC resistance. In the present study, we investigated GC sensitivity of mouse microvascular lung endothelial cells stimulated with interferon-γ (IFN-γ) and Plasmodium berghei NK65 (PbNK65). Upon challenge with IFN-γ alone, dexamethasone inhibited the expression of CCL5 (RANTES) by 90% and both CCL2 (MCP-1) and CXCL10 (IP-10) by 50%. Accordingly, whole transcriptome analysis revealed that dexamethasone differentially affected several gene clusters and in particular inhibited a large cluster of IFN-γ-induced genes, including chemokines. In contrast, combined stimulation with IFN-γ and PbNK65 extract impaired inhibitory actions of GCs on chemokine release, without affecting the capacity of the GC receptor to accumulate in the nucleus. Subsequently, we investigated the effects of GCs on two signaling pathways activated by IFN-γ. Dexamethasone left phosphorylation and protein levels of signal transducer and activator of transcription 1 (STAT1) unhampered. In contrast, dexamethasone inhibited the IFN-γ-induced activation of two mitogen-activated protein kinases (MAPK), JNK, and p38. However, PbNK65 extract abolished the inhibitory effects of GCs on MAPK signaling, inducing GC resistance. These data provide novel insights into the mechanisms of GC actions in endothelial cells and show how malaria may impair the beneficial effects of GCs.
format Online
Article
Text
id pubmed-5625030
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-56250302017-10-13 Plasmodium berghei NK65 in Combination with IFN-γ Induces Endothelial Glucocorticoid Resistance via Sustained Activation of p38 and JNK Zielińska, Karolina A. de Cauwer, Lode Knoops, Sofie Van der Molen, Kristof Sneyers, Alexander Thommis, Jonathan De Souza, J. Brian Opdenakker, Ghislain De Bosscher, Karolien Van den Steen, Philippe E. Front Immunol Immunology Malaria-associated acute respiratory distress syndrome (MA-ARDS) is an often lethal complication of malaria. Currently, no adequate therapy for this syndrome exists. Although glucocorticoids (GCs) have been used to improve clinical outcome of ARDS, their therapeutic benefits remain unclear. We previously developed a mouse model of MA-ARDS, in which dexamethasone treatment revealed GC resistance. In the present study, we investigated GC sensitivity of mouse microvascular lung endothelial cells stimulated with interferon-γ (IFN-γ) and Plasmodium berghei NK65 (PbNK65). Upon challenge with IFN-γ alone, dexamethasone inhibited the expression of CCL5 (RANTES) by 90% and both CCL2 (MCP-1) and CXCL10 (IP-10) by 50%. Accordingly, whole transcriptome analysis revealed that dexamethasone differentially affected several gene clusters and in particular inhibited a large cluster of IFN-γ-induced genes, including chemokines. In contrast, combined stimulation with IFN-γ and PbNK65 extract impaired inhibitory actions of GCs on chemokine release, without affecting the capacity of the GC receptor to accumulate in the nucleus. Subsequently, we investigated the effects of GCs on two signaling pathways activated by IFN-γ. Dexamethasone left phosphorylation and protein levels of signal transducer and activator of transcription 1 (STAT1) unhampered. In contrast, dexamethasone inhibited the IFN-γ-induced activation of two mitogen-activated protein kinases (MAPK), JNK, and p38. However, PbNK65 extract abolished the inhibitory effects of GCs on MAPK signaling, inducing GC resistance. These data provide novel insights into the mechanisms of GC actions in endothelial cells and show how malaria may impair the beneficial effects of GCs. Frontiers Media S.A. 2017-09-28 /pmc/articles/PMC5625030/ /pubmed/29033931 http://dx.doi.org/10.3389/fimmu.2017.01199 Text en Copyright © 2017 Zielińska, de Cauwer, Knoops, Van der Molen, Sneyers, Thommis, De Souza, Opdenakker, De Bosscher and Van den Steen. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Zielińska, Karolina A.
de Cauwer, Lode
Knoops, Sofie
Van der Molen, Kristof
Sneyers, Alexander
Thommis, Jonathan
De Souza, J. Brian
Opdenakker, Ghislain
De Bosscher, Karolien
Van den Steen, Philippe E.
Plasmodium berghei NK65 in Combination with IFN-γ Induces Endothelial Glucocorticoid Resistance via Sustained Activation of p38 and JNK
title Plasmodium berghei NK65 in Combination with IFN-γ Induces Endothelial Glucocorticoid Resistance via Sustained Activation of p38 and JNK
title_full Plasmodium berghei NK65 in Combination with IFN-γ Induces Endothelial Glucocorticoid Resistance via Sustained Activation of p38 and JNK
title_fullStr Plasmodium berghei NK65 in Combination with IFN-γ Induces Endothelial Glucocorticoid Resistance via Sustained Activation of p38 and JNK
title_full_unstemmed Plasmodium berghei NK65 in Combination with IFN-γ Induces Endothelial Glucocorticoid Resistance via Sustained Activation of p38 and JNK
title_short Plasmodium berghei NK65 in Combination with IFN-γ Induces Endothelial Glucocorticoid Resistance via Sustained Activation of p38 and JNK
title_sort plasmodium berghei nk65 in combination with ifn-γ induces endothelial glucocorticoid resistance via sustained activation of p38 and jnk
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625030/
https://www.ncbi.nlm.nih.gov/pubmed/29033931
http://dx.doi.org/10.3389/fimmu.2017.01199
work_keys_str_mv AT zielinskakarolinaa plasmodiumbergheink65incombinationwithifnginducesendothelialglucocorticoidresistanceviasustainedactivationofp38andjnk
AT decauwerlode plasmodiumbergheink65incombinationwithifnginducesendothelialglucocorticoidresistanceviasustainedactivationofp38andjnk
AT knoopssofie plasmodiumbergheink65incombinationwithifnginducesendothelialglucocorticoidresistanceviasustainedactivationofp38andjnk
AT vandermolenkristof plasmodiumbergheink65incombinationwithifnginducesendothelialglucocorticoidresistanceviasustainedactivationofp38andjnk
AT sneyersalexander plasmodiumbergheink65incombinationwithifnginducesendothelialglucocorticoidresistanceviasustainedactivationofp38andjnk
AT thommisjonathan plasmodiumbergheink65incombinationwithifnginducesendothelialglucocorticoidresistanceviasustainedactivationofp38andjnk
AT desouzajbrian plasmodiumbergheink65incombinationwithifnginducesendothelialglucocorticoidresistanceviasustainedactivationofp38andjnk
AT opdenakkerghislain plasmodiumbergheink65incombinationwithifnginducesendothelialglucocorticoidresistanceviasustainedactivationofp38andjnk
AT debosscherkarolien plasmodiumbergheink65incombinationwithifnginducesendothelialglucocorticoidresistanceviasustainedactivationofp38andjnk
AT vandensteenphilippee plasmodiumbergheink65incombinationwithifnginducesendothelialglucocorticoidresistanceviasustainedactivationofp38andjnk